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Abstract
Despite the introduction of antiproliferative drug-eluting stents, coronary heart disease remains the 
leading cause of death in the United States1. In-stent restenosis and bypass graft failure are 
characterized by excessive smooth muscle cell (SMC) proliferation2,3 and concomitant myointima 
formation with luminal obliteration. Here we show that during the development of myointimal 
hyperplasia in human arteries, SMCs show hyperpolarization of their mitochondrial membrane 
potential (ΔΨm) and acquire a temporary state with a high proliferative rate and resistance to 
apoptosis. Pyruvate dehydrogenase kinase isoform 2 (PDK2) was identified as a key regulatory 
protein, and its activation proved necessary for relevant myointima formation. Pharmacologic 
PDK2 blockade with dichloroacetate or lentiviral PDK2 knockdown prevented ΔΨm 
hyperpolarization, facilitated apoptosis and reduced myointima formation in injured human 
mammary and coronary arteries, rat aortas, rabbit iliac arteries and swine (pig) coronary arteries. 
In contrast to several commonly used antiproliferative drugs, dichloroacetate did not prevent 
vessel re-endothelialization. Targeting myointimal ΔΨm and alleviating apoptosis resistance is a 
novel strategy for the prevention of proliferative vascular diseases.
Balloon injury of Lewis rat aortas triggered an inflammatory response and caused leukocyte 
infiltration in the SMC-rich media after 48 h, consisting mainly of CD68-positive (CD68+) 
macrophages and some myeloperoxidase-positive (MPO+) neutrophils;CD3+ lymphocytes 
were not observed (Extended Data Fig. 1a–c). Compared to healthy, non-injured aortas, we 
observed increased phosphorylation of AKT (pAKT), and ERK1, ERK2 (pERK1/2) and ΔΨ 
m hyperpolarization in media cells of injured vessels (Extended Data Fig. 1d, e). A 
myointima subsequently developed luminal to the internal elastic lamina, which caused 
progressive luminal obliteration over 28 days (Extended Data Fig. 1f, g). This process was 
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accompanied by leukocyte infiltration and inflammatory cytokine release, which was strong 
after 7 days and markedly reduced at 28 days (Extended Data Fig. 1h, i).
A humanized model was subsequently developed to study myointima formation 
longitudinally in human arteries. Balloon-injured human internal mammary arteries (HMAs) 
were implanted into the abdominal aortic position of T-cell-deficient Rowett nude (RNU) 
rats (Supplementary Video 1). Myointimal hyperplasia rapidly developed over 4 weeks (Fig. 
1a) causing progressive luminal obliteration (Fig. 1c). By histopathology (Fig. 1b) and 
confocal immunofluorescence (Extended Data Fig. 2a, b), the myointima in the HMA model 
after 28 days or later closely resembled lesions of diseased human coronary arteries 
retrieved from autopsy samples. Using human leukocyte antigen class I (HLA I) and rat 
MHC I antibodies, the human origin of the SMCs within the myointima was confirmed 
(Extended Data Fig. 2c). Only the mechanical vessel injury was causally related to 
myointima formation and no relevant xenoantigen-triggered immune activation was 
observed (Extended Data Fig. 3a, b). Similar to the immunocompetent Lewis rat aortic 
injury model, we observed accumulation of CD68+ macrophages and MPO+ neutrophils in 
HMA vessels after 7 days, which was markedly attenuated by day 28 (Extended Data Fig. 
3c). Immune cell infiltration was again accompanied by the elevation of inflammatory 
cytokines (Extended Data Fig. 3d).
Analysis of cell growth dynamics in HMAs showed a transient but strong increase in 
proliferative activity within the myointima between 7 and 21 days after injury, accompanied 
by a persistently low rate of apoptosis (Fig. 1d, e). Proliferation and apoptosis leveled off 
after 28 days when there was also no further progression of myointimal disease (Fig. 1c, e). 
Only during the time period of highly positive net proliferation did myointimal cells 
demonstrate ΔΨm hyperpolarization (Fig. 1f). Within the myointima, cells in the luminal 
region showed higher proliferative activities and higher ΔΨm than cells closer to the media 
(Extended Data Fig. 3e).
Platelet-derived growth factor (PDGF) was suspected to be the major driving factor 
promoting myointimal hyperplasia as it was temporarily increased in injured HMA vessels 
and PDGF receptor blockade prevented the development of relevant disease (Extended Data 
Fig. 3f, g). Human vascular SMCs were isolated from fresh HMAs and characterized 
(Extended Data Fig. 4a, b). PDGF was then shown to induce ΔΨm hyperpolarization in 
cultured SMCs (Extended Data Fig. 4c), similar to the ΔΨm hyperpolarization previous 
observed in injured HMAs (Fig. 1f). Thus, mitochondrial ΔΨm hyperpolarization in 
myointimal SMCs and cultured SMCs coincided with the availability of PDGF. PDGF also 
caused a phenotype switch in SMCs from a contractile to a dedifferentiated state (Extended 
Data Fig. 4d).
Mitochondria have been shown to regulate apoptosis via their mitochondrial apoptotic 
pathway4. This involves mitochondrial permeability transition and the release of toxic 
components such as cytochrome C and caspases5. In this context, ΔΨm has an important 
role in the control of the mitochondrial permeability transition pore, as ΔΨm 
hyperpolarization has been suspected to impede pore opening6,7. Dichloroacetate (DCA), a 
rapid-acting small molecule targeting mitochondrial PDKs, has previously been 
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demonstrated to reduce ΔΨm in A549 cells8. As elevated ΔΨm and suppressed apoptosis 
have been observed after injury in our HMA model, we reasoned that DCA would prevent 
post-injury ΔΨm hyperpolarization, facilitate apoptosis and reduce myointimal growth.
DCA effectively prevented ΔΨm hyperpolarization in PDGF-treated SMCs isolated from 
either healthy or atherosclerotic vessels (Extended Data Fig. 5a, b). Previously, 
mitochondrial cytochrome C release and apoptosis induction were shown to be suppressed 
by hyperpolarized ΔΨm7,9. Consistent with this observation, PDGF reduced staurosporine-
induced mitochondrial cytochrome C leakage (Extended Data Fig. 5c, d) and rendered 
SMCs resistant to apoptosis (Extended Data Fig. 5e). DCA both increased cytochrome C 
release and restored the ability to enter apoptosis (Extended Data Fig. 5c–e).
In vivo, oral DCA did not affect leukocyte infiltration in the media of balloon-injured aortas 
in immunocompetent Lewis rats, but effectively lowered ΔΨm in the media at 48 h 
(Extended Data Fig. 6a–d). The accumulation of CD68+ macrophages and MPO+ 
neutrophils in the developing myointima was also not affected by DCA (Extended Data Fig. 
6e). However, at 7 days, DCA markedly reduced myointimal ΔΨm and permitted apoptosis 
(Extended Data Fig. 6f, h). At 28 days, ΔΨm in the developed control myointima had 
already lowered and DCA showed little effect (Extended Data Fig. 6g). Also, proliferation 
and apoptosis were low at that time point (Extended Data Fig. 6i).
The potential vasculoprotective effect of DCA was then tested in the HMA and human 
coronary artery (HCA) models (Fig. 2a–d). For the latter, HCAs with minor pre-existing 
disease, which underwent the same balloon injury and implantation procedure as described 
for HMA, were used to better reflect the coronary pathophysiology. Oral DCA 
administration strongly reduced the development of myointima and luminal narrowing in 
both HMAs (Fig. 2a) and HCAs (Fig. 2d). Similar to untreated HMA controls, the 
proliferative response to injury in DCA-treated vessels was strongest within the first 14 days 
and weakened thereafter (Fig. 2b). However, the apoptotic activity was also enhanced and 
mirrored the proliferative activity at each time point, resulting in a much lower net 
proliferation. In accordance with the in vitro data, we observed significantly lower ΔΨm in 
the 21-day HMA specimens of the DCA group (Fig. 2c). To exclude the possibility that 
ischaemia-reperfusion injury or xenogeneic immune interactions might have affected our 
results, DCA was tested further in the rat aortic (Fig. 2e) and the rabbit iliac artery balloon 
injury models (Fig. 2f). Again, myointima formation after 28 days was remarkably reduced 
by DCA in both models. Interestingly, DCA neither demonstrated anti-migratory effects on 
endothelial cells in vitro nor inhibited vessel re-endothelialization in vivo (Extended Data 
Fig. 7 and Supplementary Video 2).
PDKs are the only known targets of DCA and PDKs exclusively phosphorylate and thus 
inactivate pyruvate dehydrogenase (PDH). It was therefore suspected that PDK knockdown 
would generate similar biological effects as PDK inhibition by DCA. Although SMCs 
express PDK1, PDK2 and PDK3 (Extended Data Fig. 8a), PDK2 has the highest affinity to 
DCA10 and is likely to mediate the vast majority of the DCA effect. Therefore, PDK2-
knockdown SMCs were generated using PDK2 lentiviral short hairpin RNA (shRNA) 
(Extended Data Fig. 8b, c) to verify the mechanistic involvement of PDK2 in the DCA 
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effect. Indeed PDK2-knockdown SMCs maintained steady low ΔΨm (Extended Data Fig. 
9a) under control conditions and with PDGF stimulation. Also, PDK2-knockdown SMCs 
maintained increased cytochrome C release and elevated apoptotic rates even during PDGF 
incubation (Extended Data Fig. 9b–d). In addition, DCA lost its ability to affect ΔΨm in 
PDK2-knockdown SMCs (Extended Data Fig. 9a). As expected, when PDH (the primary 
inhibitory target of PDK2) was knocked down (Extended Data Fig. 9e) instead of PDK2, the 
opposite effect was observed: ΔΨm was permanently elevated, even under control 
conditions (Extended Data Fig. 9f). DCA again lost its ability to depolarize ΔΨm, indicating 
that the DCA effect on ΔΨm depended on both PDK2 and PDH.
To assess whether arteries with ex vivo PDK2 knockdown would develop similarly reduced 
myointima as arteries under DCA treatment, PDK2 knockdown was induced in HMAs and 
HCAs before implantation (Extended Data Fig. 8d–f). Comparable to the DCA group, 
PDK2-knockdown HMAs showed low net proliferation throughout the 28-day study period 
(Fig. 3a). ΔΨm hyperpolarization was also effectively prevented and the low ΔΨm of PDK2 
knockdown HMAs at day 21 (Fig. 3b) closely resembled the ΔΨm values of DCA-treated 
HMAs (Fig. 2c). Reduced luminal obliteration was observed in both PDK2-knockdown 
HMAs (Fig. 3c) and HCAs (Fig. 3d) at day 28.
DCA was ultimately evaluated in a translationally relevant swine model of coronary artery 
restenosis. Yorkshire swine underwent standardized coronary artery balloon injury under 
fluoroscopic guidance. After 28 days, DCA-treated animals showed significantly reduced 
luminal obliteration, proliferation area, and max. proliferation thickness (Fig. 4a–d). In 
summary, DCA reduced myointima formation in five different preclinical in vivo models.
Upon PDGF stimulation of cultured SMCs, we observed an activation of the downstream 
PI(3)K (phosphatidylinositol-3-OHkinase) and MEK (MAPK kinase) pathways with AKT 
phosphorylation, ERK1 and ERK2 phosphorylation, hexokinase 2 (HK2) upregulation, and 
increased HK2–mitochondrial association (Extended Data Fig. 10a–d). HK2 has previously 
been shown to have a binding site close to VDAC (voltage-dependent anion-selective 
channel), the most abundant protein of the outer mitochondrial membrane, and HK2 binding 
was reported to reduce channel conductance11,12. Consistent with this previous work, we 
show that HK2–mitochondrial association coincides with ΔΨm hyperpolarization and 
apoptosis resistance in our study. Furthermore, displacement of HK2 from its mitochondrial 
VDAC binding site both reduced ΔΨm and restored the susceptibility to apoptosis 
(Extended Data Fig. 10e). VDAC closure using the inhibitor DIDS also increased SMC 
ΔΨm and reduced apoptosis (Extended Data Fig. 10f), further supporting the direct 
mechanistic involvement of VDAC in the regulation of both ΔΨm and apoptosis.
DCA and PDK2 knockdown diminished HK2 elevation (Extended Data Fig. 10b) and HK2–
mitochondrial association (Extended Data Fig. 10c, d), and maintained low ΔΨm despite 
PDGF (Extended Data Fig. 10g). Notably, it was confirmed that the depolarizing effects of 
DCA and PDK2 knockdown on ΔΨm were ultimately mediated through VDAC, because 
inhibition of VDAC opening by DIDS was found to neutralize these effects (Extended Data 
Fig. 10g). However, the mechanistic link between PDK2 inhibition and the decrease in 
HK2-VDAC binding and reversal of ΔΨm hyperpolarization remains elusive.
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In healthy vessels, proliferation and apoptosis are very low and balanced13. Vessel injury 
disrupts this homeostasis and triggers an inflammatory state14–16, which induces temporary 
ΔΨm hyperpolarization in SMCs and drives myointima formation. As shown here, PDK2 
repression counteracts temporarily acquired apoptosis resistance and may be a well-tolerated 
strategy for the prevention of restenosis without interfering with re-endothelialization.
METHODS
Animal models
HMAs were obtained during routine coronary artery bypass surgery and HCAs without 
stenotic disease or calcifications were obtained from patients <50 years of age undergoing 
heart transplantation for dilated cardiomyopathy. The use of leftover arteries from the 
operating room for research was approved by the Institutional Review Board (IRB) and 
patients gave their written informed consent. Human myointimal hyperplasia was induced in 
HMAs and HCAs by balloon injury using a 2-French Fogarty catheter and the human 
arteries were implanted into the abdominal aortic position of male athymic RNU rats (8 
weeks old; Crl:NIH-Foxn1rnu; Charles River, Sulzfeld, Germany). Male Lewis rats (8 weeks 
old) and male New Zealand rabbits (12 weeks old, Charles River) underwent balloon injury 
of their abdominal aortas or their iliac arteries, respectively, using Fogarty catheters. Rats 
and rabbits in the DCA groups were treated with DCA (0.75 g l−1 in drinking water, Sigma, 
Munich, Germany). The PDGF-R blocker imatinib (50 mg kg−1 day−1, oral) was 
administered in one experiment. Animals were excluded if they died prematurely or became 
sick, as diagnosed by a veterinarian. Vessels in the PDK2-knockdown HMA or HCA groups 
underwent ex vivo PDK2 knockdown on the day before implantation. Rat and rabbit studies 
were approved by the Hamburg Amt für Gesundheit und Verbraucherschutz. Naturally 
diseased human coronary artery samples were recovered at autopsy from patients with 
myointimal hyperplasia at 54 to 63 years of age.
Swine study
Swine experiments were performed according to the protocol approved by the Stanford 
University Administrative Panel on Laboratory Animal Care (APLAC). A total of 10 female 
juvenile Yorkshire swine (40–50 kg, 12–14 weeks old) were used for this study. Swine were 
pretreated with aspirin (650 mg) and nifedipine (30 mg) orally at least 12 h before the injury 
procedure. The animals were sedated with telazol (6 mg kg−1, intramuscular), followed by 
inhalant mask induction (isoflurane 4–5%). Following intubation, anaesthesia was 
maintained with 1–3% isoflurane in a mixture of oxygen and air. Animals were placed in the 
supine position and continuous electrocardiography and haemodynamic monitoring were 
performed throughout all procedures.
Vascular access was obtained using a standard 6-French vascular sheath placed in the right 
or left carotid and/or femoral arteries, as necessary. All animals received pre-procedural 
heparin (300 IU kg−1, intra-arterial) and an activated clotting time was maintained at >300 s.
After advancing a 6-French guiding catheter through the aorta into the coronary ostia, an 
intracoronary injection of 0.2 mg nitroglycerin was administered and baseline coronary 
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angiography was performed to identify the desirable location for the lesion based on 
coronary artery size and anatomy. A 0.014-inch percutaneous transluminal coronary 
angioplasty guidewire was advanced through the guiding catheter into the coronary artery. A 
bare metal coronary stent was implanted distal to the target lesion site to achieve a 1.05–
1.15:1 stent–artery ratio as a marker. Balloon injury was induced at 10–20 mm proximal 
from the marker stent to achieve a 1.3–1.35:1 balloon–artery overstretch. The balloon was 
inflated for 30 s twice with a 30-s interval. Three coronary arteries, the left anterior 
descending artery, the circumflex artery and the right coronary artery were used in all 
animals. Subsequently, coronary artery patency was confirmed by coronary artery 
angiography. The animals were weaned from mechanical ventilation and allowed to recover 
in their normal housing at the animal care facility. Swine in the treatment group received 
DCA at 25 mg kg−1 three times a day. The animals were monitored daily until the time of 
coronary artery retrieval at 4 weeks after euthanasia. A total of 45 sections were analysed 
per group (three sections per vessel, three coronary arteries per pig, five pigs per group).
Histology and immunohistochemistry
Vessels were stained with Masson’s trichrome for quantification of the luminal obliteration, 
which was defined as the percentage of the cross-sectional area within the internal elastic 
lamina taken up by the myointima. The overview vessel images in the figures show cropped 
vessels without surrounding tissue. RECA-1 (HIS52, Serotec, Raleigh, North Carolina) was 
used to stain endothelium. CD3 (SP7), CD68 (ED1, Abcam) and MPO (no.475915, 
Calbiochem) staining characterized leukocyte infiltration.
Cytokine antibody array
Injured rat aortas or HMAs were recovered and homogenized in cell lysing buffer (including 
proteinase inhibitor) using the Qiagen Tissue Lyser. Tissue lysate (400 µg) was diluted in 1 
ml assay buffer and membranes were incubated for 2 h at 20–25 °C followed by antibody 
incubation according to the protocol. Cytokine antibody arrays for PDGF, IFNγ, MCP-1, 
MIP-3α, and IL-1β (Raybiotech, Norcross, Georgia, USA) were performed according to the 
manufacturer’s protocol. The membranes were digitized using bioluminescence imaging and 
quantified using NIH ImageJ. Cytokine concentration is expressed in arbitrary units (AU).
Cell culture
Human vascular SMCs were freshly isolated from HMA or atherosclerotic coronary arteries 
using papain (1 mg ml−1), dithiothreitol (0.5 mg ml−1), collagenase (0.6 mg ml−1) and 
bovine serum albumin (0.6 mg ml−1, Sigma). SMCs were used for experiments when they 
were 70–80% confluent. SMCs were incubated with PDGF (50 ng ml−1) for 48h and/or 
DCA (5 mM; DCA treatment was started 2 days before PDGF) if not indicated otherwise. 
The VDAC inhibitor diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS, 0.5 mM for 24 h, 
Sigma) or HXK2VBD-cpm, a cell-permeable peptide analogue of the HK2-VDACbinding 
domain (100 µM, Advanced Peptide, Boston, MA), were used in some assays.
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PDK2 knockdown
Lentiviral shRNA particles targeting PDK2 (Santa Cruz, Santa Cruz, California) were used 
to knock down PDK2 ex vivo before HMA or HCA implantation, and in vitro using human 
SMCs. Lentiviral particles were a pool of three different shRNA plasmids: 5′-
GATCCCCAAGTACATAGAGCACTTTTCAAGAGAAAGTGCTCTATGTACTTGGTT
TTT-3′, 5′-
GATCCGACCGATGCTGTCATCTATTTCAAGAGAATAGATGACAGCATCGGTCTT
TTT-3′, 5′-
GATCCCCAACTCTAAAGTGGAAGATTCAAGAGATCTTCCACTTTAGAGTTGGTT
TTT-3′.
shRNA lentiviral particles containing an shRNA construct encoding a scrambled sequence 
served as control. Vessels were inflated with lentiviral-particle-containing medium (1 × 106 
infectious units of virus per 200 µl); human SMCs were transduced at a multiplicity of 
infection of 50. Successfully transduced PDK2-knockdown SMCs were purified using 
puromycin.
PDH knockdown
SMCs (3 × 104) were transfected with 80 pmol of siRNA targeting PDH (Santa Cruz) in 
OptiMem (Gibco, Grand Island, New York) supplemented with transfection reagent (Santa 
Cruz) at 37 °C and 5% CO2. PDH siRNA was a pool of three different siRNA duplexes: 
sense, 5′-CAGAUCAGCUGUAUAAACATT-3′; antisense, 5′-
UGUUUAUACAGCUGAUCUGTT-3′; sense, 5′-GGAUUGCUCUAGCCUGUAATT-3′; 
antisense, 5′-UUACAGGCUAGAGCAAUCCTT-3′; sense, 5′-
CUGUCACAUUCCUAUUUCUTT-3′, antisense: 5′-
AGAAAUAGGAAUGUGACAGTT-3′.
After 6 h, the same volume of normal growth medium containing two times the normal 
serum and antibiotics concentration was added without removing the transfection mixture. 
After an additional 24 h, medium was replaced and cells were used for experiments 48 h 
after the transfection.
Elispot assays
For uni-directional Elispot assays, recipient splenocytes were isolated from fresh spleen 7 
days after HMA or aortic transplantation and used as responder cells. Donor-specific non-
transplanted HMA or aortic tissues were homogenized and single cells were mitomycin-
inhibited and served as stimulator cells. Stimulator cells (105) were incubated with 106 
recipient responder splenocytes for 24 h and IFNγ spot frequencies were automatically 
counted using an Elispot plate reader.
Endothelial-cell scratch assay
Endothelial cells (5 × 105 per well) were plated onto 6-well plates. When cells reached 
confluence, a scratch was made across the cell monolayer using a pipette tip (scratch width, 
338 µm). Time to closure was monitored by living cell imaging (Improvision Spinning Disk; 
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Perkin Elmer, Waltham, Massachusetts, magnification × 100) for 24h. In addition, 
endothelial cells that migrated into the 340 µm × 338 µm scratch area were counted after 5 h.
Organ chamber experiments
Fresh vascular rings of rat aorta were cut into 4-mm segments and mounted in phosphate-
buffer-filled organ chambers gassed with 95% oxygen and 5% carbon dioxide. After pre-
constriction with prostaglandin F2α (15 µl 10−2 M in 25 ml buffer) to achieve 50–80% of 
the maximal KCl-induced tone, increasing concentrations of nitroglycerin (NTG, 10−9 M to 
10−4.5 M) or acetylcholine (10−9 M to 10−5.5 M) were added for relaxation studies. 
Endothelium-dependent (acetylcholine) and -independent (NTG) vasodilator responses were 
assessed with denuded aortic rings serving as negative controls for endothelial function.
Immunoblot analysis
Proteins were separated on SDS–PAGE gels (Invitrogen, Carlsbad, California) and western 
blot analyses were conducted with specific antibodies to pAKT (D9E), pERK1/2 (#9101), 
GAPDH (14C10, Cell Signaling, Irvine, California), HK2 (1A7), PDH (9H9), PDK1 (C20), 
PDK2 (N20), PDK3 (N14), PDK4 (C16, Santa Cruz), SMA (ab5694), CV (ab110415), β-
actin (ACTN05 (C4), Abcam), cytochrome C (6H2.B4, Calbiochem, Darmstadt, Germany), 
myocardin (355521, R+D Systems, Minneapolis, Minnesota), and SMemb (3H2, Yamasa, 
Tokyo, Japan). The membranes were digitized using bioluminescence imaging and 
quantified using NIH ImageJ. GAPDH or β-actin served as housekeeping control.
RNA quantification and PCR
Total RNA was isolated with a TRIzol-based (Invitrogen) RNA isolation protocol and RNA 
was quantified by NanoDrop (NanoDrop ND-1000, Peqlab, Erlangen, Germany). Samples 
required 260:280 ratios of >1.8 for inclusion. RNA was reverse-transcribed with the High 
Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, California) 
according to them anufacturer’s instructions. Quantitative determination of RNA was 
performed by real-time RT–PCR with POWER SYBR Green PCR Master Mix (Applied 
Biosystems) according to the manufacturer’s instructions. Primers were used specific for 
every human sequence. Particularly, the primers used to amplify PDK1-4 were: PDK1 
forward, 5′-AGTGCCTCTGGCTGGTTTTGG-3′ and reverse, 5′-
CGTGGTTGGTGTTGTAATGCTTCC-3′; PDK2 forward, 5′-
GCAAGTTCTCCCCGTCCCCG-3′ and reverse, 5′-
GGACATACCAGCTCTGCACCAG-3′; PDK3 forward, 5′-
CAGAGCTGCCCCTTTGGCTGG-3′ and reverse, 5′-TGGCGCCATGCGGACTTATT-3′ 
and PDK4 forward, 5′-TGGTAGCAGTGGTCCAAGATGCC-3′ and reverse, 5′-
CAACTGTTGCCCGCATTGCAT-3′. Absolute and relative RNA levels of PDK1, PDK2, 
PDK3 and PDK4 were determined to endogenous GAPDH. c-KIT RNA was amplified using 
primers forward, 5′-CACCGAAGGAGGCATTACAC-3′ and reverse, 5’-
GGAATCCTGCTGCCACACA-3′. SMA RNA was amplified using primers forward, 5′-
GCGTGGCTATTCCTTCGTTA-3′ and reverse, 5′-ATGAAGGATGGCTGGAACAG-3′. 
SM22 RNA was amplified using primers forward, 5′-AACAGCCTGTACCCTGATGG-3′ 
and reverse, 5′-CGGTAGTGCCCATCATTCTT-3′. Experiments were performed on the 
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7900 HT Sequence Detection System (Applied Biosystems). The amount of RNA was 
estimated according to the comparative Ct method with the 2-ΔΔCt formula.
Immunofluorescence staining
Tissues were fixed with 4% paraformaldehyde, dehydrated and embedded in paraffin. After 
heat-induced antigen retrieval with Dako antigen retrieval solution (Dako, Glostrup, 
Denmark) in a steamer for 20 min, 3-µm paraffin sections were blocked with Image-iT FX 
signal enhancer (Invitrogen) for 30 min. Primary antibodies of following sources were used: 
SMA (ab5694), SM heavy chain (EPR5335), SM22 (ab10135), calponin (CALP), 
smoothelin (R4A, Abcam), Ki67 (SP6), CD3 (SP7), PDK1 (C20), PDK2 (N20), human 
leukocyte antigen I (HLAI, 3F10, Santa Cruz), myocardin (355521, R+D Systems), and rat 
major histocompatibility complex I (MHC I, B5) conjugated with FITC (BD Pharmingen). 
Except for MHC I staining, all other studies included incubation with a corresponding 
secondary antibody conjugated to Alexa Fluor 488, Alexa Fluor 555, or Alexa Fluor 647 
(Invitrogen). Sections were incubated with antibodies for 1 h at 37 °C, followed by cell 
nucleus staining with DAPI for 10 min. Imaging was performed using a Nikon Eclipse TiE 
microscope (Nikon, Tokyo, Japan) equipped with the Perkin Elmer UltraVIEW VoX 
confocal imaging system (Perkin Elmer, Waltham, Massachusetts). Analysis was carried out 
with Volocity 6.1.1 (Perkin Elmer).
For co-localization of HK2 and mitochondria, confocal images stained for HK2 (1A7, Santa 
Cruz), MitoTracker (Invitrogen), and DAPI were obtained with the confocal Nikon Eclipse 
TiE microscope.
Flow cytometry by FACS
Primary antibodies used to characterize SMCs were SMA (ab5694), SM22 (ab10135), 
calponin (CALP), smoothelin (R4A, Abcam), and myocardin (355521, R+D Systems). 
Samples were measured on a FACSCalibur system (Becton Dickinson, Heidelberg, 
Germany) and analysed using FlowJo (Tree Star, Ashland, Oregon). In the histograms, the 
isotype controls are displayed in grey and the antigens of interest in green.
TMRM staining
To measure ΔΨm, freshly isolated tissues or cells were incubated with tetramethylrhodamine 
methyl ester perchlorate (TMRM, 10 nM; Invitrogen) and Hoechst 33342 (0.3 µM; 
Invitrogen) for 30 min at 37 °C. Subsequently, samples were washed to remove unbound 
dye and immediately imaged. In vitro, 5 × 104 SMCs were plated on confocal dishes and 
cells were stimulated according to their group-specific protocol. Vessels were freshly cut 
under the microscope into thin slices and were timely stained and analysed. Fluorescence 
signal was measured using a Nikon Eclipse TiE microscope equipped with Perkin Elmer 
UltraVIEW VoXconfocal imaging system. Analysis was carried out on Volocity 6.1.1. For 
analysis, mean TMRM-fluorescence intensity was calculated by dividing individual object 
fluorescence intensities by sizes (number of voxels) and is expressed in arbitrary 
fluorescence units (FU).
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Cytochrome C staining
To measure cytochrome-C-related apoptosis, cells were stained for cytochrome C after 
staurosporine treatment (50 nM; Sigma) for 18 h. Cells were then fixed in 4% 
paraformaldehyde, permeabilized with Permeabilization Solution (Applied StemCell, Menlo 
Park, California), and blocked with Blocking Solution (Applied StemCell). After incubation 
with a mouse antibody against cytochrome C (6H2.B4, Calbiochem) for 16 h at 4 °C, a goat 
anti-mouse antibody conjugated with Alexa Flour 488 (Invitrogen) was used as the 
secondary antibody (1 h, 37 °C). Cell nuclei were counterstained with DAPI. Examination 
was carried out with a Nikon Eclipse TiE microscope equipped with Perkin Elmer 
UltraVIEW VoX confocal imaging system, followed by analysis with Volocity 6.1.1. For 
analysis, cells showing diffuse cytoplasmatic cytochrome C staining overlying the nucleus 
were counted and divided by the number of DAPI positive cells to obtain the percentage of 
cells with cytochrome C leakage.
TUNEL staining
SMCs were treated with staurosporine (50 nM; Sigma) for 18 h to induce apoptosis. 
ApopTag apoptosis detection kit (TUNEL; Merck Millipore, Darmstadt, Germany) was then 
used according to manufacturer’s instructions to label apoptotic cells. Similarly, tissue 
sections, processed as described in “Immunofluorescence staining”, underwent heat-induced 
antigen retrieval with Dako antigen retrieval solution (Dako) in a streamer for 20 min, 
followed by blocking with Image-iT FX signal enhancer (Invitrogen) for 30 min. Staining 
was performed according to manufacturer’s instructions using the ApopTag apoptosis 
detection kit. Nuclei were counterstained with DAPI. The percentage of TUNEL-positive 
cells was calculated.
Statistics
Owing to the exploratory character of this study and the fact that an inhibitory effect of 
DCA on myointima formation has not been described yet, there were no data for an initial 
power analysis. Usually, five to seven animals were randomized to one group. All samples 
were number coded until the readout was finalized. The numbers were assigned before the 
experiment and determined the group, treatment and condition. The surgeons performing the 
procedures and the scientists performing the readouts were blinded. All values are expressed 
as mean ± s.d. or mean ± s.e.m. as indicated. Intergroup differences were appropriately 
assessed by either unpaired two-tailed Student’s t-test or one-way analysis of variance 
(ANOVA) with Bonferroni’s post-hoc test. If data were normalized to the control group, 
one-sample t-tests against 1.0 were used for study groups. * P < 0.05, **P < 0.01.
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Extended Data
Extended Data Figure 1. Myointima formation in balloon-injured rat aortas
a, b, Forty-eight hours after mechanical injury, trichrome (a) and immunofluorescence for 
SMC-markers (b) identified abundant SMCs in the aortic media. c, The infiltrate at 48 h was 
composed of CD68+ macrophages, some MPO+ neutrophils, and no CD3+ lymphocytes. d, 
Phosphorylation of AKT (pAKT), and ERK1 and ERK2 (pERK1/2), was markedly 
increased as early as 30 min after injury (mean ± s.d., n = 6 animals per group, control after 
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30 min normalized to healthy media, one-sample t-tests). e, Media cells of injured aortas 
showed ΔΨm hyperpolarization after 48 h (mean ± s.d., n = 4 animals (healthy media), 6 
animals (control after 48 h), Student’s t-test). f, g, A myointima developed over 28 days in 
injured rat aortas (f, trichrome) and caused luminal obliteration (g, mean ± s.d., n = 5 
animals (day 0), 4 animals (day 7), 6 animals (day 28), ANOVA with Bonferroni’s post-hoc 
test). h, Many infiltrating macrophages and very few neutrophils were observed in the 
myointima at 7 days. Leukocyte infiltration was sparse at 28 days; no lymphocytes were 
found (black arrows, internal elastic lamina). i, Tissue IFNγ, MCP-1, MIP-3α, and IL-1β 
levels were markedly increased at 7 days and were diminished after 28 days (mean ± s.d., n 
= 3 animals (day 0), 4 animals (day 7 and 28), days 7 and 28 normalized to day 0, one-
sample t-test (day 0 versus day 7), Student’s t-test (day 7 versus day 28)). *P < 0.05; **P < 
0.01.
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Extended Data Figure 2. Characterization of the human internal mammary artery model
a, b, Sections were co-stained for the SMC markers smoothelin, SM22, and calponin (a) or 
SMA, smooth muscle myosin (SM) heavy chain and myocardin (b). Co-localization could 
be observed in the merged pictures (white arrows, internal elastic lamina, pictures are 
representative of two replicates). Direct comparison between the HMA myointima on day 28 
with the myointima in diseased human coronary artery (HCA) samples illustrated close 
similarities in immunofluorescence morphology. c, The human origin of myointimal cells in 
21-day control HMAs was confirmed. Trichrome showed the development of a cell-rich 
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myointima with mild fibrosis. Specimens were stained for SMA, DAPI and human 
leukocyte antigen class I (HLA I, upper row) or rat major histocompatibility complex class I 
(rat MHC I, lower row). Cells expressing SMA (red) co-expressed HLA I (green), which 
resulted in a yellow staining in the merged picture. No co-expression of SMA and rat MHC I 
was observed.
Extended Data Figure 3. The central role for PDGF in advancing myointima formation
a, After 28 days, non-denuded HMAs in RNU rats showed only minor myointimal lesions 
(trichrome, mean ± s.d., n = 5 animals). b, To evaluate a possible rejection process in the 
xenogeneic HMA setting, host immune activation and graft infiltration were assessed. In the 
HMA model, xenogeneic HMA were transplanted into RNU rats (middle column). 
Xenogeneic HMA transplants into immunocompetent hosts (Brown Norway rats; BN, left 
column) and syngeneic RNU aortic transplants into RNU recipients (right column) served as 
controls; all analyses were performed after 7 days. Para-aortic BN lymph nodes harboured 
huge amounts of CD3+ lymphocytes, whereas the number was low in RNU lymph nodes. In 
IFNγ-Elispot assays with homogenized graft cells and recipient splenocytes, only BN 
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recipients showed strong immune activation, whereas RNU recipients failed to mount a 
relevant immune response (box 25th to 75th percentile with median, whiskers min–max, 
quadruplicates of 5 animals (columns 1 and 2) and 4 animals (column 3), ANOVA with 
Bonferroni’s post-hoc test). Dense CD3+ infiltrates were found in HMA grafts of BN 
recipients, but not in HMA or RNU aortic grafts in RNU recipients. c, 
Immunohistochemistry identified myointimal macrophages and neutrophils in HMA control 
specimens on day 7 and reduced leukocyte infiltration in control specimens on day 28. 
Lymphocytes were not observed (black arrows, internal elastic lamina). d, HMA tissue 
levels of the inflammatory cytokines IFNγ, MCP-1, MIP-3α, and IL-1β were elevated 
during the first 14 days (mean ± s.d., n = 3 animals per group, ANOVA with Bonferroni’s 
post-hoc test). e, In HMA day 21 vessels, spatial differences of SMC ΔΨm with higher 
TMRM fluorescence in the luminal areas compared to the areas adjacent to the media were 
observed. SMC proliferation also mainly occurred in these luminal regions of elevated ΔΨm. 
DIC, differential interference contrast. f, Tissue PDGF was increased in HMA after injury 
and peaked after 14 days (mean ± s.d., n = 3 animals per time point, ANOVA with 
Bonferroni’s post-hoc test). g, Compared to untreated control vessels at day 28 in the rat 
aortic balloon injury model (Extended Data Fig. 1g), imatinib (PDGF-R blocker)-treated 28-
day vessels showed only minor lesions (mean ± s.d., n = 8 animals). *P < 0.05; **P < 0.01.
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Extended Data Figure 4. SMC characterization and response to PDGF
a, b, Cells isolated from fresh HMA were positive for SMA, myocardin, smoothelin, 
calponin, and SM22α (SM22) as detected by FACS (a, pictures are representative of three 
replicates) and immunofluorescence (b, pictures are representative of three replicates). Thus, 
cells were identified as SMCs, but we cannot rule out that cells from other sources (for 
example, vessel wall stem cells with smooth muscle characteristics) were also involved. c, 
ΔΨm hyperpolarization, a phenomenon observed at times of maximized net proliferative 
activity in HMA (Fig. 1f), could be linked to PDGF. When SMCs were incubated with 
PDGF, ΔΨm hyperpolarization steadily increased over time, reaching its maximum after 48 
h (mean ± s.d., 5 replicates of 2 (15 min, 2 h) or 3 (all other groups) independent 
experiments, ANOVA with Bonferroni’s post-hoc test). d, We found a significant 
downregulation of c-KIT, SMA and SM22 mRNA versus GAPDH mRNA after incubation 
with PDGF, all maturity markers for contractile SMCs (mean ± s.d., 13 independent 
experiments, Student’s t-test). Western blot analysis further revealed a downregulation of 
myocardin and confirmed SMA reduction. In contrast, SMemb, the embryonic form of 
smooth muscle myosin heavy chain and a marker for dedifferentiated SMCs, was increased, 
indicating a PDGF-induced phenotype switch (mean ± s.d., 5 (myocardin and SMA) and 6 
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(SMemb) independent experiments, PDGF normalized to control, one-sample t-tests). *P < 
0.05; **P < 0.01.
Extended Data Figure 5. DCA reduces ΔΨm hyperpolarization and facilitates apoptosis in SMCs
a, To assess the kinetics of DCA action in vitro, SMCs were pre-incubated with DCA for 
different time periods and then stimulated with PDGF for 48 h (mean ± s.d., 10 replicates of 
3 independent experiments per group, ANOVA with Bonferroni’s post-hoc test). DCA 
reduced PDGF-induced ΔΨm hyperpolarization irrespective of the pre-incubation period. b, 
Atherosclerotic plaques from heavily calcified and atherosclerotic human coronary arteries 
were scraped off the media and cultured in SMC medium. Outgrowing SMCs were picked 
and expanded. PDGF significantly increased ΔΨm, an effect that was prevented by DCA 
(mean ± s.d., 10 replicates of 3 independent experiments, ANOVA with Bonferroni’s post-
hoc test). c–e, Apoptosis induction with staurosporine significantly increased the number of 
control SMCs that showed cytochrome C leakage, as identified by diffuse cytochrome C 
staining throughout the cell (c, mean ± s.d., 10 replicates of 2 independent experiments per 
group, ANOVA with Bonferroni’s post-hoc test). PDGF significantly reduced cytochrome C 
release in SMCs and DCA counteracted this PDGF effect. Cytoplasmatic (C) and 
mitochondrial fractions (M) were isolated for immunoblotting (d, data are representative of 
3 independent experiments). Separation was confirmed by the contents of mitochondrial 
complex V (CV) and cytosolic GAPDH. Cytochrome C was retained inside the 
mitochondria in control SMCs and was released with staurosporine. PDGF reduced the 
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cytoplasmatic fraction, indicating reduced cytochrome C release, and DCA reversed the 
PDGF effect. SMC apoptosis was detected by TUNEL staining (e, mean ± s.d., 10 replicates 
of 2 (column 1) or 3 (columns 2–4) independent experiments, ANOVA with Bonferroni’s 
post-hoc test). Staurosporine significantly increased the number of apoptotic control SMCs. 
PDGF treatment decreased the percentage of apoptotic SMCs and DCA reversed this anti-
apoptotic effect. *P < 0.05; **P < 0.01.
Extended Data Figure 6. DCA lowers medial and myointimal ΔΨm and facilitates apoptosis in 
balloon-injured rat aortas
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a, b, Trichrome (a) and immunofluorescence (b) confirmed abundant SMCs in the aortic 
media of DCA-treated animals 48h after injury. c, Similar to control vessels, the infiltrate 
mainly contained macrophages and neutrophils, but no CD3+ lymphocytes. d, DCA reduced 
ΔΨm of medial cells (mean ± s.d., n = 6 animals (control at 48 h) and 4 animals (DCA at 48 
h), Student’s t-test). e, Macrophages were the main inflammatory cell population in the 
developing myointima of immunocompetent DCA animals at 7 days. Very few neutrophils 
and no lymphocytes were observed. Leukocyte infiltration was markedly alleviated at 28 
days (black arrows, internal elastic lamina). f, g, DCA effectively lowered the elevated ΔΨm 
of myointimal cells on day 7 (f, mean ± s.d., n = 4 animals per group, Student’s t-test), but 
had little effect on the already reduced ΔΨm at 28 days (g, mean ± s.d., n = 6 animals per 
group, Student’s t-test). h, i, The percentages of proliferating (Ki67+) and apoptotic 
(TUNEL+) cells in the myointima were calculated (representative cropped pictures of the 
myointima are presented). The few myointimal cells in control- and DCA-vessels at 7 days 
showed high proliferative activity (red, positive y axis), but apoptosis (green, negative y 
axis) was only observed in DCA-treated animals (h, mean ± s.e.m., n = 4 animals per 
group). Proliferation and apoptosis were low after 28 days in both groups (i, mean ± s.e.m., 
n = 5 animals (control at day 28) and 7 animals (DCA at day 28)). *P < 0.05.
Extended Data Figure 7. DCA does not impair endothelial cell migration or vessel re-
endothelialization
The effect of DCA on endothelial cell (EC) migration was assessed in vitro. a, b, A scratch 
(width 338 µm) was made across a confluent human EC monolayer. The number of cells 
that migrated into a 340 µm × 338 µm scratch rectangle within 5 h was counted (a, mean ± 
s.d., triplicates of 3 independent experiments, Student’s t-test) and the time needed to close 
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the scratch was recorded (b, mean ± s.d., n = 5 (EC), 4 (EC + DCA) independent 
experiments, Student’s t-test). There were no differences between untreated and DCA-
treated ECs. c, d, To evaluate vessel re-endothelialization, rat aortas underwent mechanical 
endothelial denudation by balloon injury. Aortas were recovered after 28 days and stained 
for rat endothelial cell antigen (c, black arrows, RECA-1). Re-endothelialization was 
quantified (d, mean ± s.d., n = 5 animals (control at day 28) and 6 animals (DCA at day 28), 
Student’s t-test) and was similar in both groups. e, f, Endothelial function in both 28-day 
groups was further assessed in relaxation studies and compared to denuded aortas three days 
after balloon injury (mean ± s.e.m., n = 9 animals (control at day 28), 11 animals (DCA at 
day 28) and 3 animals (denuded at day 3)). Freshly recovered aortic segments were pre-
constricted and DCA-treated and control vessels, as well as denuded aortas, showed similar 
endothelium-independent relaxation capacities using nitroglycerin (NTG) as vasodilator (e). 
However, denuded aortas largely failed to show endothelium-dependent relaxation with 
acetylcholine (Ach; f). Both DCA-treated and control vessels demonstrated similar and 
physiologic endothelium-dependent relaxation, indicating functional integrity of the vascular 
endothelium.
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Extended Data Figure 8. PDK2 knockdown in SMCs, HMAs and HCAs
a, PDK1, PDK2, PDK3 and PDK4 mRNA expression was assessed in control SMCs and 
normalized to GAPDH (mean ± s.d., 3 independent experiments). PDK1, PDK2 and PDK3 
mRNA was detected as shown. Also, PDK1, PDK2 and PDK3 but not PDK4 were 
detectable in immunoblot analyses (data are representative of 3 independent experiments). b, 
To confirm in vitro PDK2 knockdown, PDK1 and PDK2 expressions were assessed in 
immunoblot analyses (data are representative of 3 independent experiments). PDK2 was 
markedly reduced in PDK2-knockdown SMCs (PDK2-KD-SMC), but not in scramble 
shRNA-transduced SMCs (scramble-SMC). PDK1 expression remained unaffected by 
PDK2- or scramble-shRNA constructs. c, To exclude that lentiviral shRNA transduction 
changed the ΔΨm response to PDGF, scramble-SMCs were stimulated with PDGF (mean ± 
s.d., 10 replicates of 2 independent experiments, Student’s t-test). Both the baseline potential 
and the PDGF-triggered increase in ΔΨm were similar to SMCs (see Extended Data Fig. 5a). 
d, Fresh HMA vessels underwent balloon injury, were divided, and one half was sampled 
(day -1). The other half was incubated with lentiviral particles containing PDK2 or 
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scrambled shRNA. On the next day, transduced vessels were transplanted into RNU rats. 
Two days later, vessels were recovered (day 2) for immunoblotting. PDK2 could be detected 
in untreated HMA vessels (day -1). On day 2, only scrambled control HMAs, but not PDK2-
KD vessels showed a PDK2 signal (data are representative of 3 independent experiments). e, 
f, After 28 days, HMA and HCA samples were stained for DAPI, PDK1, PDK2 and SMA. 
PDK1 was similarly detectable in all control, scramble and PDK2-KD sections at day 28 (e, 
pictures are representative of 3 independent experiments). At day 28, HMA control and 
scramble as well as HCA control showed detectable PDK2 protein, whereas PDK2 
fluorescence in HMA and HCA PDK2-KD at day 28 was negligible (f, pictures are 
representative of 3 independent experiments), demonstrating selective knockdown. **P < 
0.01.
Extended Data Figure 9. PDK2 knockdown mimics the DCA effect on SMC ΔΨm and apoptosis
a, PDK2-KD-SMCs were pre-incubated with DCA and/or stimulated with PDGF. PDK2-
KD-SMCs maintained low ΔΨm despite PDGF stimulation and DCA did not further 
depolarize ΔΨm (mean ± s.d., 10 replicates of 3 (columns 1 and 3) or 4 (column 2) 
independent experiments, ANOVA with Bonferroni’s post-hoc test). b, c, Apoptosis was 
induced with staurosporine. Control PDK2-KD-SMCs showed mainly mitochondria-housed 
cytochrome C in fluorescence stainings (b, mean ± s.d., 10 replicates of 2 independent 
experiments, ANOVA with Bonferroni’s post-hoc test) and compartment-separated 
immunoblot analyses (c, data are representative of 2 independent experiments). After 
induction of apoptosis, cytochrome C leaked into the cytoplasm and PDGF did not suppress 
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cytochrome C leakage. d, PDGF did not induce resistance to apoptosis in PDK2-KD-SMCs 
(mean ± s.d., 10 replicates of 2 independent experiments per group, ANOVA with 
Bonferroni’s post-hoc test). e, To establish a link between PDH and ΔΨm, PDH was 
knocked down (data are representative of 2 independent experiments). f, ΔΨm was 
significantly increased in PDH siRNA-transfected SMCs and PDGF and DCA no longer 
affected ΔΨm (mean ± s.d., 10 replicates of 2 (column 2) or 3 (columns 1, 3, 4 and 5) 
independent experiments, ANOVA with Bonferroni’s post-hoc test). **P < 0.01.
Extended Data Figure 10. VDAC controls ΔΨm and apoptosis
a, PDGF stimulation of SMCs significantly increased phosphorylated AKT, and ERK1 and 
ERK2, and increased the expression of HK2 (mean ± s.d., 5 (pAKT and pERK1/2) and 8 
(HK2) independent experiments, PDGF normalized to control, one-sample t-tests). b, 
Immunoblot analysis revealed PDGF-induced upregulation of HK2 expression in SMCs 
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(mean ± s.d., 3 (SMC) independent experiments, data normalized to control, one-sample t-
test (control versus PDGF), Student’s t-test (PDGF versus PDGF + DCA)). HK2 
upregulation was alleviated by DCA or PDK2-KD (mean ± s.d., 8 (PDK2-KD-SMC) 
independent experiments, PDGF normalized to control, one-sample t-test). c, Confocal 
images with mitochondrial (MitoTracker, red), HK2 (green), and nuclear staining (DAPI, 
blue, data are representative of 2 independent experiments) were captured. Co-localization 
of green HK2 with red mitochondria generated a yellow colour. SMCs incubated with 
PDGF increased their yellow signal, an effect that was prevented by DCA. PDGF did not 
induce HK2-mitochondrial association in PDK2-KD-SMCs. d, Cytoplasmatic (C) and 
mitochondrial fractions (M) were isolated for immunoblotting (data are representative of 2 
independent experiments). In control SMCs and PDK2-KD-SMCs, HK2 was mainly 
detected in the cytoplasmatic fraction. In SMCs, PDGF caused a partial translocation of 
HK2 to the mitochondrial compartment. DCA markedly alleviated this translocation. PDGF 
did not induce HK2 translocation in PDK2-KD-SMCs. e, In the presence of HXK2VBD-
cpm, PDGF failed to induce both ΔΨm hyperpolarization (mean ± s.d., 10 replicates of 3 
independent experiments, ANOVA with Bonferroni’s post-hoc test) and apoptosis resistance 
(mean ± s.d., 10 replicates of 3 independent experiments, ANOVA with Bonferroni’s post-
hoc test). f, VDAC inhibition by DIDS caused ΔΨm hyperpolarization (mean ± s.d., 10 
replicates of 2 independent experiments, Student’s t-test) and rendered SMCs resistant to 
staurosporine-induced apoptosis (mean ± s.d., 10 replicates of 3 independent experiments, 
ANOVA with Bonferroni’s post-hoc test). g, The depolarizing effect of DCA on PDGF-
treated SMCs was counteracted by DIDS (mean ± s.d., 10 replicates of 3 independent 
experiments, ANOVA with Bonferroni’s post-hoc test). Although PDGF did not increase 
ΔΨm in PDK2-KD-SMC, DIDS caused marked mitochondrial hyperpolarization (mean ± 
s.d., 10 replicates of 2 independent experiments, ANOVA with Bonferroni’s post-hoc test). 
*P < 0.05; **P < 0.01.
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Figure 1. Chronology and growth dynamics of myointima formation in the HMA model
a, Development of myointimal hyperplasia (trichrome; black arrows, internal elastic 
lamina). b, Non-calcified lesions in naturally diseased human coronary artery (HCA). c, 
Luminal obliteration over time (mean ± s.d., n = 5 animals (days 0–28), 4 animals (days 42–
60), ANOVA with Bonferroni’s post-hoc test). d, e, The timeline of proliferative (Ki67) and 
apoptotic activity (TUNEL, TdT-mediated dUTP nick end labelling) within the myointima 
was monitored by immunofluorescence (d) and quantified (e, mean ± s.e.m., n = 7 animals 
(day 7), 5 animals (day 14), 6 animals (days 21–60)). Net proliferation was calculated as the 
percentage of Ki67-positive minus TUNEL-positive cells. BF, brightfield. f, ΔΨm in HMA 
myointima (mean ± s.d., n = 5 animals (day 14), 9 animals (day 21), 6 animals (days 28–42), 
ANOVA with Bonferroni’s post-hoc test). FU, arbitrary fluorescence units; TMRM, 
tetramethylrhodamine methyl ester perchlorate assay. *P < 0.05, **P < 0.01.
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Figure 2. DCA alleviates myointima formation in vivo
a, After 28 days, luminal obliteration was significantly less in the DCA group of the HMA 
model (mean ± s.d., n = 5 animals per group, Student’s t-test). In animals treated for 60 days 
(n = 4), there was no further disease progression. b, Myointimal growth dynamics in the 
HMA DCA group (mean ± s.e.m., n = 4 animals (day 7), 5 animals (day 14), 3 animals (day 
21), 6 animals (day 28)). c, At day 21, ΔΨm was significantly lower in HMA DCA vessels 
than in control arteries (mean ± s.d., n = 9 control animals, n = 4 DCA animals, Student’s t-
test). d, At day 28, DCA reduced luminal obliteration in the HCA model (mean ± s.d., n = 8 
control animals, n = 14 DCA animals, Student’s t-test). e, f, At day 28, DCA effectively 
alleviated myointima formation in balloon-injured rat aortas (e, mean ± s.d., n = 6 animals 
per group, Student’s t-test) and rabbit iliac arteries (f, mean ± s.d., n = 12 control animals, n 
= 15 DCA animals, Student’s t-test). **P < 0.01.
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Figure 3. PDK2 knockdown alleviates myointima formation in vivo
a, PDK2-knockdown HMAs showed elevated apoptosis rates during the early time points of 
increased proliferative activity resulting in low myointimal net proliferation (mean ± s.e.m., 
n = 3 (day 7), 4 (day 14), 3 (day 21), 8 (day 28) animals). b, At day 21, ΔΨm in PDK2-
knockdown HMA vessels was approximately as low as in DCA HMA vessels (mean ± s.d., 
n = 4 animals; see Fig. 2c). c, At day 28, luminal obliteration was significantly reduced in 
PDK2-knockdown HMA compared to scrambled shRNA controls (mean ± s.d., n = 4 
animals (scramble) and n = 9 animals (PDK2-knockdown, Student’s t-test). d, Luminal 
obliteration was low in PDK2-knockdown HCA vessels at day 28 (mean ± s.d., n = 3 
animals). **P < 0.01.
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Figure 4. DCA effectively reduces balloon-injury-induced myointima formation in swine 
coronary arteries in vivo
a, After 28 days, the coronary arteries of untreated and DCA-treated Yorkshire swine were 
retrieved (trichrome). One representative vessel per animal is presented. b, The patent lumen 
inside the external elastic lamina (EEL) was significantly larger in the DCA group (mean ± 
s.d., n = 45 sections per group (three sections per vessel, three coronary arteries per pig, five 
pigs per group), Student’s t-test). Thus, DCA significantly alleviated myointima formation. 
c, d, In the region of a ruptured internal elastic lamina, the proliferation area (c) and the 
maximal proliferation thickness (d) were significantly smaller with DCA (mean ± s.d., n = 
42 control sections, n = 31 DCA sections, Student’s t-test). **P < 0.01.
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